Pilot hospital patient trials conducted at JSS Ayurveda Medical College and Hospital, Mysore, India in 2014 showed significant improvements in fasting blood sugar results after taking Glycostat ® at 1, 3, and 6 months
Data adopted from Glykon Technologies Group, LLC
Patent application US 2015/0125887A1 showed that Glycostat ® improved glucose uptake and supported insulin sensitivity in the hepatocytes (liver cells).
Data adopted from United States Patent Application Publication, Clouatre et.al. (2015)